ResMed, Inspire Medical fall after Lillys Zepbound gains sleep apnea indication
| RMD Stock | USD 233.18 0.70 0.30% |
About 62% of ResMed's investor base is looking to short. The analysis of overall sentiment of trading ResMed Inc stock suggests that many investors are alarmed at this time. The current market sentiment, together with ResMed's historical and current headlines, can help investors time the market. In addition, many technical investors use ResMed Inc stock news signals to limit their universe of possible portfolio assets.
ResMed |
ResMed and Inspire Medical Systems stocks drop as Eli Lillys Zepbound gains new sleep apnea indication for obese individuals on Dec.
Read at seekingalpha.com
 |
ResMed Fundamental Analysis
We analyze ResMed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
ResMed is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
ResMed Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ResMed stock to make a market-neutral strategy. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics with similar companies.
Peers
ResMed Related Equities
| BDX | Becton Dickinson | 0.16 | ||||
| WST | West Pharmaceutical | 0.06 | ||||
| HOLX | Hologic | 0.17 | ||||
| COO | Cooper Companies, | 0.29 | ||||
| BAX | Baxter International | 0.34 | ||||
| TFX | Teleflex Incorporated | 0.35 | ||||
| EMBC | Embecta Corp | 0.62 | ||||
| ALC | Alcon AG | 0.75 | ||||
| MMSI | Merit Medical | 1.16 | ||||
| ICUI | ICU Medical | 1.28 | ||||
| STAA | STAAR Surgical | 1.59 |
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |